KGP-25 is an inhibitor of voltage-gated sodium channel 1.8 (Nav1.8), which can be used for analgesia by targeting Nav1.8 in the peripheral nervous system (PNS). KGP-25 can also target gamma-aminobutyric acid subtype A receptor (GABAA) in the central nervous system (CNS) for general anesthesia[1].
Molecular Weight:
357.92
Purity:
95
Formula:
C19H32ClNO3
Target:
GABA Receptor,Sodium Channel
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
